444 results
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: European Medicines Agency recommends limiting long-term use of calcitonin medicines
CHMP, Last updated: 20/07/2012Medicines Agency recommends limiting long-term use of calcitonin … Medicines Agency recommends limiting long-term use of calcitonin … Medicines Agency recommends limiting long- term use of calcitonin … -
List item
News: First antibody-drug conjugate for multiple myeloma patients with limited treatment options
CHMP, Last updated: 24/07/2020multiple myeloma patients with limited treatment options … multiple myeloma patients with limited treatment options … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 February 2017
CHMP, Last updated: 24/02/2017Pemetrexed Hospira UK Limited … -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020aligned recommendations for limiting nitrosamine impurities in … main change concerns the limits for nitrosamines, which previously … products (e.g. tablets). These limits, based on internationally … -
List item
News: New treatment for people with dwarfism
CHMP, Last updated: 25/06/2021affected by the condition are limited to supportive care and surgical … surgical interventions to extend limb length, correct spinal compression … both the spine and the lower limbs. Longer-term data in number … -
List item
Press release: New treatment option recommended for patients with advanced melanoma
CHMP, Last updated: 22/05/2015However, this therapy has limited benefits for patients with … blocking a cellular pathway that limits the immune system from fighting … However, this therapy has limited benefits for patients with … -
List item
Press release: Mysimba recommended for approval in weight management in adults
CHMP, Last updated: 19/12/2014for weight management are limited. Mysimba is a prolonged release … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 April 2008
CHMP, Last updated: 29/04/2008from CV Therapeutics Europe Limited, for the treatment of stable … -
List item
Press release: European Medicines Agency completes review of polymyxin-based medicines
CHMP, Last updated: 24/10/2014effects. Due in part to this limited use, colistimethate sodium … other treatment options are limited. The medicine should be given … quickly. Although data were very limited, the Committee recommended … -
List item
Press release: New medicine for hereditary angioedema, a rare disease causing swelling beneath the skin
CHMP, Last updated: 19/10/2018body, such as in the face, limbs, gut and larynx. It is caused … -
List item
Press release: European Medicines Agency recommends approval of pomalidomide for the treatment of multiple myeloma
CHMP, Last updated: 31/05/2013group of patients has very limited treatment options. Pomalidomide … malformed, short or missing limbs, and other severe, life-threatening … group of patients has very limited treatment options. Pomalidomide … -
List item
Press release: Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight
CHMP, Last updated: 24/07/2014the data available are too limited and not robust enough to … ulipristal acetate, although limited data from clinical trials … effect, the data are too limited and insufficiently precise … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 24-27 July 2006
CHMP, Last updated: 28/07/2006varenicline), from Pfizer Limited. The approved indication is … varenicline), from Pfizer Limited. The approved indication is … pregabalin), from Pfizer Limited, to extend its indication … -
List item
Press release: Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities
CHMP, Last updated: 01/02/2019during which strict temporary limits on levels of these impurities … -
List item
Press release: HPV vaccines: EMA confirms evidence does not support that they cause CRPS or POTS
CHMP, Last updated: 20/11/2015pain syndrome affecting a limb, while POTS is a condition … pain syndrome affecting a limb, while POTS is a condition … long-lasting pain affecting a limb, and POTS is associated with … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2018
CHMP, Last updated: 23/02/2018Marketing-authorisation applicant Biocryst UK Limited Therapeutic indication Treatment … -
List item
News: Public statement on the cessation of marketing of exubera (Insulin human)
CHMP, Last updated: 19/11/2007responsible for Exubera is Pfizer Limited. The European Medicines Agency … responsible for Exubera is Pfizer Limited. The European Medicines Agency … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2017
CHMP, Last updated: 27/01/2017Marketing-authorisation applicant Pfizer Limited Therapeutic indication Treatment … -
List item
Press release: Boosting care for newborn babies in low-income countries
CHMP, Last updated: 29/04/2016care centres in resource-limited settings. The studies also … regulatory capacity may be limited, by providing an expert evaluation … care centres in resource-limited settings. The studies also … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020
CHMP, Last updated: 24/07/2020Complex in adults with limited treatment options who do … -
List item
Press release: New medicine to help in the fight against antimicrobial resistance
CHMP, Last updated: 29/04/2016approval for patients with limited treatment options … approval for patients with limited treatment options The … for which there are only limited treatment options. The … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018Tetraphase Pharmaceuticals Ireland Limited Therapeutic indication Treatment … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021
CHMP, Last updated: 26/02/2021GlaxoSmithKline (Ireland) Limited Therapeutic indication Treatment … -
List item
Press release: European Medicines Agency confirms positive benefit-risk balance for Champix
CHMP, Last updated: 21/07/2011Committee identified a number of limitations of the meta-analysis, including … an event. Because of these limitations, the Committee could not draw … Committee identified a number of limitations of the meta-analysis, including … -
List item
Press release: European Medicines Agency updates on ongoing benefit-risk review of pioglitazone–containing medicines
CHMP, Last updated: 23/06/2011had several methodological limitations, which limit the strength of evidence … had several methodological limitations, which limit the strength of evidence …